Gurban CV and Mederle O |
The OPG/RANKL system and zinc ions are promoters of bone remodeling by osteoblast proliferation in postmenopausal osteoporosis. |
2011 |
Rom J Morphol Embryol |
pmid:22119834
|
Ostrowska Z et al. |
Circadian concentrations of free testosterone, selected markers of bone metabolism, osteoprotegerin and its ligand sRANKL in obese postmenopausal women. |
2011 |
Postepy Hig Med Dosw (Online) |
pmid:22100799
|
Sood SK et al. |
Osteoprotegerin (OPG) and related proteins (RANK, RANKL and TRAIL) in thyroid disease. |
2011 |
World J Surg |
pmid:21748518
|
Stein SH and Tipton DA |
Vitamin D and its impact on oral health--an update. |
2011 |
J Tenn Dent Assoc |
pmid:21748977
|
Xie H et al. |
Omentin-1 attenuates arterial calcification and bone loss in osteoprotegerin-deficient mice by inhibition of RANKL expression. |
2011 |
Cardiovasc. Res. |
pmid:21750093
|
Wang Y et al. |
Alendronate (ALN) combined with osteoprotegerin (OPG) significantly improves mechanical properties of long bone than the single use of ALN or OPG in the ovariectomized rats. |
2011 |
J Orthop Surg Res |
pmid:21752290
|
Plasilova M et al. |
Discordant gene expression signatures and related phenotypic differences in lamin A- and A/C-related Hutchinson-Gilford progeria syndrome (HGPS). |
2011 |
PLoS ONE |
pmid:21738662
|
Lossdörfer S et al. |
PTH(1-34)-induced changes in RANKL and OPG expression by human PDL cells modify osteoclast biology in a co-culture model with RAW 264.7 cells. |
2011 |
Clin Oral Investig |
pmid:20697756
|
Tipton DA et al. |
Effect of bisphosphonates on human gingival fibroblast production of mediators of osteoclastogenesis: RANKL, osteoprotegerin and interleukin-6. |
2011 |
J. Periodont. Res. |
pmid:20701670
|
Persson E and Lerner UH |
The neuropeptide VIP regulates the expression of osteoclastogenic factors in osteoblasts. |
2011 |
J. Cell. Biochem. |
pmid:21815197
|
Üstündağ M et al. |
The role of serum osteoprotegerin and S-100 protein levels in patients with acute ischaemic stroke: determination of stroke subtype, severity and mortality. |
2011 |
J. Int. Med. Res. |
pmid:21819709
|
Bellido M et al. |
Improving subchondral bone integrity reduces progression of cartilage damage in experimental osteoarthritis preceded by osteoporosis. |
2011 |
Osteoarthr. Cartil. |
pmid:21820069
|
Lawrie A et al. |
Paigen diet-fed apolipoprotein E knockout mice develop severe pulmonary hypertension in an interleukin-1-dependent manner. |
2011 |
Am. J. Pathol. |
pmid:21835155
|
Poulsen MK et al. |
Plasma osteoprotegerin is related to carotid and peripheral arterial disease, but not to myocardial ischemia in type 2 diabetes mellitus. |
2011 |
Cardiovasc Diabetol |
pmid:21838881
|
Markatseli AE et al. |
Association of the A1330V and V667M polymorphisms of LRP5 with bone mineral density in Greek peri- and postmenopausal women. |
2011 |
Maturitas |
pmid:21840657
|
Sudrová M et al. |
Influence of long-term thromboprophylaxis with low-molecular-weight heparin (enoxaparin) on changes of bone metabolism markers in pregnant women. |
2011 |
Clin. Appl. Thromb. Hemost. |
pmid:20682598
|
Mamalis AA et al. |
Chemical modification of an implant surface increases osteogenesis and simultaneously reduces osteoclastogenesis: an in vitro study. |
2011 |
Clin Oral Implants Res |
pmid:21070383
|
Vitoratos N et al. |
Maternal circulating osteoprotegerin and soluble RANKL in pre-eclamptic women. |
2011 |
Eur. J. Obstet. Gynecol. Reprod. Biol. |
pmid:21074311
|
Belibasakis GN et al. |
Oral biofilm challenge regulates the RANKL-OPG system in periodontal ligament and dental pulp cells. |
2011 |
Microb. Pathog. |
pmid:21075196
|
Wattanaroonwong N et al. |
Oestrogen inhibits osteoclast formation induced by periodontal ligament fibroblasts. |
2011 |
Arch. Oral Biol. |
pmid:21035111
|
Fradet A et al. |
Dual function of ERRα in breast cancer and bone metastasis formation: implication of VEGF and osteoprotegerin. |
2011 |
Cancer Res. |
pmid:21734015
|
Kaneko K and Kawai S |
[Mechanisms and therapeutics of glucocorticoid-induced osteoporosis]. |
2011 |
Nihon Rinsho Meneki Gakkai Kaishi |
pmid:21720102
|
Zhang Y et al. |
Study of the mechanisms by which Sambucus williamsii HANCE extract exert protective effects against ovariectomy-induced osteoporosis in vivo. |
2011 |
Osteoporos Int |
pmid:20414641
|
Hie M and Tsukamoto I |
Vitamin C-deficiency stimulates osteoclastogenesis with an increase in RANK expression. |
2011 |
J. Nutr. Biochem. |
pmid:20444587
|
El-Shehaby A et al. |
Correlations of urinary biomarkers, TNF-like weak inducer of apoptosis (TWEAK), osteoprotegerin (OPG), monocyte chemoattractant protein-1 (MCP-1), and IL-8 with lupus nephritis. |
2011 |
J. Clin. Immunol. |
pmid:21691937
|
Nich C et al. |
Oestrogen deficiency modulates particle-induced osteolysis. |
2011 |
Arthritis Res. Ther. |
pmid:21696618
|
Belibasakis GN et al. |
Porphyromonas gingivalis induces RANKL in T-cells. |
2011 |
Inflammation |
pmid:20446027
|
Clézardin P |
[The role of RANK/RANKL/osteoprotegerin (OPG) triad in cancer-induced bone diseases: physiopathology and clinical implications]. |
2011 |
Bull Cancer |
pmid:21700551
|
Celczyńska Bajew L et al. |
The effects of osteoprotegerin (OPG) gene polymorphism in patients with ischaemic heart disease on the morphology of coronary arteries and bone mineral density. |
2011 |
Kardiol Pol |
pmid:21678294
|
Dzida G |
[Decalcified bones, calcified heart?]. |
2011 |
Kardiol Pol |
pmid:21678295
|
Yang Q et al. |
Plasma osteoprotegerin levels and long-term prognosis in patients with intermediate coronary artery lesions. |
2011 |
Clin Cardiol |
pmid:21678453
|
Toffoli B et al. |
Osteoprotegerin promotes vascular fibrosis via a TGF-β1 autocrine loop. |
2011 |
Atherosclerosis |
pmid:21679949
|
de Moraes M et al. |
Comparative immunohistochemical expression of RANK, RANKL and OPG in radicular and dentigerous cysts. |
2011 |
Arch. Oral Biol. |
pmid:21683340
|
Roshandel D et al. |
Influence of polymorphisms in the RANKL/RANK/OPG signaling pathway on volumetric bone mineral density and bone geometry at the forearm in men. |
2011 |
Calcif. Tissue Int. |
pmid:21964949
|
Davenport C et al. |
Identifying coronary artery disease in men with type 2 diabetes: osteoprotegerin, pulse wave velocity, and other biomarkers of cardiovascular risk. |
2011 |
J. Hypertens. |
pmid:21970938
|
Miyamoto K et al. |
Osteoclasts are dispensable for hematopoietic stem cell maintenance and mobilization. |
2011 |
J. Exp. Med. |
pmid:22006978
|
Quemerais-Durieu MA et al. |
[Therapeutic innovation in osteoporosis (antisclerostin antibody and denosumab)]. |
2011 |
Ann. Endocrinol. (Paris) |
pmid:22008272
|
Koo HM et al. |
Elevated osteoprotegerin is associated with inflammation, malnutrition and new onset cardiovascular events in peritoneal dialysis patients. |
2011 |
Atherosclerosis |
pmid:22015178
|
Cao H et al. |
Dysregulated atrial gene expression of osteoprotegerin/receptor activator of nuclear factor-κB (RANK)/RANK ligand axis in the development and progression of atrial fibrillation. |
2011 |
Circ. J. |
pmid:22001292
|
Scialla JJ et al. |
Correlates of osteoprotegerin and association with aortic pulse wave velocity in patients with chronic kidney disease. |
2011 |
Clin J Am Soc Nephrol |
pmid:21940840
|
Cianciolo G et al. |
Effects of unfractioned heparin and low-molecular-weight heparin on osteoprotegerin and RANKL plasma levels in haemodialysis patients. |
2011 |
Nephrol. Dial. Transplant. |
pmid:20659908
|
Dimitrow PP et al. |
The influence of statins on levels of calcification biomarkers in patients with aortic sclerosis or mild aortic stenosis. |
2011 |
J. Heart Valve Dis. |
pmid:21404893
|
Marques EA et al. |
Effects of resistance and aerobic exercise on physical function, bone mineral density, OPG and RANKL in older women. |
2011 |
Exp. Gerontol. |
pmid:21316442
|
Chin A et al. |
Effects of medicinal herb salvia miltiorrhiza on osteoblastic cells in vitro. |
2011 |
J. Orthop. Res. |
pmid:21319217
|
Mencej-BedraÄ S et al. |
TNFRSF11B gene polymorphisms 1181G > C and 245T > G as well as haplotype CT influence bone mineral density in postmenopausal women. |
2011 |
Maturitas |
pmid:21411255
|
Lee JC et al. |
Role of RANK-RANKL-OPG axis in cranial suture homeostasis. |
2011 |
J Craniofac Surg |
pmid:21415639
|
Goto H et al. |
Human bone marrow adipocytes support dexamethasone-induced osteoclast differentiation and function through RANKL expression. |
2011 |
Biomed. Res. |
pmid:21383509
|
Mainini G et al. |
Serum osteoprotegerin correlates with age and bone mass in postmenopausal, but not in fertile age women. |
2011 |
Clin Exp Obstet Gynecol |
pmid:22268274
|
Riksen EA et al. |
Human osteoblastic cells discriminate between 20-kDa amelogenin isoforms. |
2011 |
Eur. J. Oral Sci. |
pmid:22243268
|
Yang Z et al. |
[Effects of negative pressure on osteogenesis in human bone marrow-derived stroma cells cultured in vitro]. |
2011 |
Zhongguo Gu Shang |
pmid:22276514
|
Liang QQ et al. |
The expression of osteoprotegerin is required for maintaining the intervertebral disc endplate of aged mice. |
2011 |
Bone |
pmid:21466864
|
Honda K |
Interleukin-6 and soluble interleukin-6 receptor suppress osteoclastic differentiation by inducing PGE(2) production in chondrocytes. |
2011 |
J Oral Sci |
pmid:21467819
|
Moldenhauer A et al. |
Interleukin 32 promotes hematopoietic progenitor expansion and attenuates bone marrow cytotoxicity. |
2011 |
Eur. J. Immunol. |
pmid:21469100
|
Kim H et al. |
Association between Wnt signaling pathway gene polymorphisms and bone response to hormone therapy in postmenopausal Korean women. |
2011 |
Menopause |
pmid:21471826
|
Mulcahy LE et al. |
RANKL and OPG activity is regulated by injury size in networks of osteocyte-like cells. |
2011 |
Bone |
pmid:20854946
|
Aspenberg P et al. |
Targeting RANKL for reduction of bone loss around unstable implants: OPG-Fc compared to alendronate in a model for mechanically induced loosening. |
2011 |
Bone |
pmid:20858557
|
Kurnatowska I et al. |
Serum osteoprotegerin is a predictor of progression of atherosclerosis and coronary calcification in hemodialysis patients. |
2011 |
Nephron Clin Pract |
pmid:20861651
|
de Souza Faloni AP et al. |
Jaw and long bone marrows have a different osteoclastogenic potential. |
2011 |
Calcif. Tissue Int. |
pmid:20862464
|
Yu H et al. |
Overexpression of osteoprotegerin promotes preosteoblast differentiation to mature osteoblasts. |
2011 |
Angle Orthod |
pmid:20936961
|
Palaniswamy C et al. |
Association of warfarin use with valvular and vascular calcification: a review. |
2011 |
Clin Cardiol |
pmid:21298649
|
Bostanci N et al. |
Effect of periodontal treatment on receptor activator of NF-κB ligand and osteoprotegerin levels and relative ratio in gingival crevicular fluid. |
2011 |
J. Clin. Periodontol. |
pmid:21261673
|
Andersen GØ et al. |
Elevated serum osteoprotegerin levels measured early after acute ST-elevation myocardial infarction predict final infarct size. |
2011 |
Heart |
pmid:21270073
|
Tsukamoto S et al. |
Clinical significance of osteoprotegerin expression in human colorectal cancer. |
2011 |
Clin. Cancer Res. |
pmid:21270110
|
Monnouchi S et al. |
The roles of angiotensin II in stretched periodontal ligament cells. |
2011 |
J. Dent. Res. |
pmid:21270461
|
Chang YH et al. |
Serum osteoprotegerin and tumor necrosis factor related apoptosis inducing-ligand (TRAIL) are elevated in type 2 diabetic patients with albuminuria and serum osteoprotegerin is independently associated with the severity of diabetic nephropathy. |
2011 |
Metab. Clin. Exp. |
pmid:21251686
|
Bai P et al. |
Disturbance of the OPG/RANK/RANKL pathway and systemic inflammation in COPD patients with emphysema and osteoporosis. |
2011 |
Respir. Res. |
pmid:22176920
|
Piedra M et al. |
"Single nucleotide polymorphisms of the OPG/RANKL system genes in primary hyperparathyroidism and their relationship with bone mineral density". |
2011 |
BMC Med. Genet. |
pmid:22185226
|
Kawaguchi H |
[Approach for therapeutic targets of osteoarthritis]. |
2011 |
Nippon Yakurigaku Zasshi |
pmid:21747205
|
Nahidi L et al. |
Osteoprotegerin in pediatric Crohn's disease and the effects of exclusive enteral nutrition. |
2011 |
Inflamm. Bowel Dis. |
pmid:20848544
|
Čolović M et al. |
FGF-R3 and OPG expression in patient with multiple myeloma following systemic sclerosis: case report and review of the literature. |
2011 |
Int. J. Hematol. |
pmid:21207214
|
Hashiguchi D et al. |
Mineral trioxide aggregate solution inhibits osteoclast differentiation through the maintenance of osteoprotegerin expression in osteoblasts. |
2011 |
J Biomed Mater Res A |
pmid:21171155
|
Li JY et al. |
Ovariectomy disregulates osteoblast and osteoclast formation through the T-cell receptor CD40 ligand. |
2011 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:21187391
|
Kuczkowski J et al. |
Expression of the receptor activator for nuclear factor-κB ligand and osteoprotegerin in chronic otitis media. |
2010 Nov-Dec |
Am J Otolaryngol |
pmid:20015790
|
Kuczkowski J et al. |
[Molecular control of bone resorption in chronic otitis media with cholesteatoma]. |
2010 Jul-Aug |
Otolaryngol Pol |
pmid:20873097
|
Reyes-GarcÃa R et al. |
Effects of alendronate treatment on serum levels of osteoprotegerin and total receptor activator of nuclear factor kappaB in women with postmenopausal osteoporosis. |
2010 Jan-Feb |
Menopause |
pmid:19574937
|
Mori K et al. |
Effects of pravastatin on serum osteoprotegerin levels in patients with hypercholesterolemia and type 2 diabetes. |
2010 Feb-Mar |
Angiology |
pmid:19147525
|
Verdrengh M et al. |
RANKL-targeted therapy inhibits bone resorption in experimental Staphylococcus aureus-induced arthritis. |
2010 |
Bone |
pmid:19879986
|
Nuntapornsak A et al. |
Changes in the mRNA expression of osteoblast-related genes in response to beta(3)-adrenergic agonist in UMR106 cells. |
2010 |
Cell Biochem. Funct. |
pmid:19827007
|
Deng S et al. |
Regulatory effect of vasoactive intestinal peptide on the balance of Treg and Th17 in collagen-induced arthritis. |
2010 |
Cell. Immunol. |
pmid:20716449
|
Hu Y et al. |
Layer-by-layer assembly of β-estradiol loaded mesoporous silica nanoparticles on titanium substrates and its implication for bone homeostasis. |
2010 |
Adv. Mater. Weinheim |
pmid:20717987
|
Bae YJ and Kim MH |
Calcium and Magnesium Supplementation Improves Serum OPG/RANKL in Calcium-Deficient Ovariectomized Rats. |
2010 |
Calcif. Tissue Int. |
pmid:20811796
|
Akiyama T et al. |
PEDF regulates osteoclasts via osteoprotegerin and RANKL. |
2010 |
Biochem. Biophys. Res. Commun. |
pmid:19945427
|
Yamaguchi A and Akashi T |
[Vascular calcification: mutual interaction between bone and blood vessel]. |
2010 |
Clin Calcium |
pmid:21037387
|
Yoshida M et al. |
[Vascular calcification and serum markers]. |
2010 |
Clin Calcium |
pmid:21037390
|
Venuraju SM et al. |
Osteoprotegerin as a predictor of coronary artery disease and cardiovascular mortality and morbidity. |
2010 |
J. Am. Coll. Cardiol. |
pmid:20447527
|
Lieb W et al. |
Biomarkers of the osteoprotegerin pathway: clinical correlates, subclinical disease, incident cardiovascular disease, and mortality. |
2010 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:20448212
|
Xu M et al. |
Basal bone phenotype and increased anabolic responses to intermittent parathyroid hormone in healthy male COX-2 knockout mice. |
2010 |
Bone |
pmid:20471507
|
Bu YH et al. |
Insulin receptor substrate 1 regulates the cellular differentiation and the matrix metallopeptidase expression of preosteoblastic cells. |
2010 |
J. Endocrinol. |
pmid:20525764
|
Yang Y et al. |
Functional analysis of core binding factor a1 and its relationship with related genes expressed by human periodontal ligament cells exposed to mechanical stress. |
2010 |
Eur J Orthod |
pmid:20525800
|
Hope S et al. |
Osteoprotegerin levels in patients with severe mental disorders. |
2010 |
J Psychiatry Neurosci |
pmid:20569643
|
Komosińska-Vassev K et al. |
[Osteoporosis--pathophysiology and laboratory diagnostic methods]. |
2010 |
Prz. Lek. |
pmid:21387765
|
Mysliwiec J et al. |
Role of interleukin-6 on RANKL-RANK/osteoprotegerin system in hypothyroid ovariectomized mice. |
2010 |
Folia Histochem. Cytobiol. |
pmid:21478097
|
Pérez-Sayáns M et al. |
RANK/RANKL/OPG role in distraction osteogenesis. |
2010 |
Oral Surg Oral Med Oral Pathol Oral Radiol Endod |
pmid:20163972
|
Buckle CH et al. |
Targeting RANK/RANKL in the treatment of solid tumours and myeloma. |
2010 |
Curr. Pharm. Des. |
pmid:20166980
|
Jiang XY et al. |
A polymorphism near osteoprotegerin gene confer risk of obesity in Uyghurs. |
2010 |
Endocrine |
pmid:20960157
|
Enjuanes A et al. |
The effect of the alendronate on OPG/RANKL system in differentiated primary human osteoblasts. |
2010 |
Endocrine |
pmid:20960270
|
Benedikt MB et al. |
2-methoxyestradiol-mediated anti-tumor effect increases osteoprotegerin expression in osteosarcoma cells. |
2010 |
J. Cell. Biochem. |
pmid:20082321
|
Christoforidis A et al. |
Increased osteoclastic activity as shown by increased sRANK-L/OPG ratio in boys with hemophilia. |
2010 |
Ann. Hematol. |
pmid:20084381
|
Shiota J et al. |
[Relationship between coronary and abdominal calcification score, serum osteoprotegerin (OPG), and serum tartrate-resistant acid phosphatase (TRACP) -5b in pre-dialysis CKD patients]. |
2010 |
Nihon Jinzo Gakkai Shi |
pmid:21254698
|
Tokuyama N and Tanaka S |
[Cytokines in bone diseases. Genetic disorders of RANKL-RANK-OPG system]. |
2010 |
Clin Calcium |
pmid:20890036
|